Canute Pharma Limited

Canute Pharma Ltd from Knutsford UK is a small, active company founded five years ago. With eight employees and £864,562 in assets, it’s a modest operation led by one director and owner. The company has a real address and is regularly involved in importing and exporting pharmaceutical products—41 months of imports and 20 months of exports recorded.

The company's website, Canute Pharma, indicates it operates in the manufacture of medical and dental instruments and supplies. It appears to be a private limited company, with a focus on providing pharmaceutical products. The company is also linked to J J S Pharma (uk) Limited, suggesting a broader network within the pharmaceutical sector.

Financially, Canute Pharma Ltd shows a mixed picture. While current assets are up slightly at £860,000, net assets have declined significantly by 13%, settling at -£840,000. Bank borrowings have also increased, reaching £270,000, and cash reserves have fallen sharply by 88% to just £11,000. Creditors have decreased by 0.79%, which could indicate improved debt management. The company meets the criteria for a small company, with turnover under £10.2m, assets under £5.1m, and fewer than 50 employees. Accumulated amortisation of intangible assets has also increased by 11%, which could be a cause for concern.

The company’s reliance on imports and exports suggests a global supply chain, but the declining cash reserves and increasing bank borrowings raise questions about its financial health. The lack of an auditor mentioned (likely exempt as a small company) means the figures are unaudited. Overall, Canute Pharma Ltd seems to be navigating a challenging environment, needing to balance its trading activities with its financial stability.

Registered in England/Wales under the registration number 12545506, with a registered address at WA16 6EN, United Kingdom, Knutsford, Cheshire, Ground Floor, 3 Royal Court, Tatton Street.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.